These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 61194)

  • 21. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical results of synchronised radiotherapy on a theoretical and experimental basis (author's transl)].
    Ammon J; Winkel K zum ; Giesen M; Schwab W; Palme G
    Z Laryngol Rhinol Otol; 1973 Nov; 52(11):825-32. PubMed ID: 4204263
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy in recurrent heat and neck cancer.
    Simmonds WP
    Otolaryngol Clin North Am; 1974 Feb; 7(1):205-15. PubMed ID: 4130287
    [No Abstract]   [Full Text] [Related]  

  • 24. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
    Marcial VA; Pajak TF; Kramer S; Davis LW; Stetz J; Laramore GE; Jacobs JR; Al-Sarraf M; Brady LW
    Semin Oncol; 1988 Feb; 15(1):39-60. PubMed ID: 3278390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
    Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nursing implications related to chemotherapy for head and neck cancer.
    Newton M; Wulf BG
    Plast Surg Nurs; 1985; 5(4):135-41. PubMed ID: 2421366
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy of head and neck carcinomas].
    Schenone G; Bussi M; Magnano M; De Stefani A; Cavalot A; Rosso S; Merlano M; Cortesina G
    Acta Otorhinolaryngol Ital; 1997 Apr; 17(2):124-35. PubMed ID: 9441562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemo-radiotherapy in advanced head and neck tumors. Personal experience].
    Buffoli A; Morrica B; Frata P; La Face B
    Radiol Med; 1992 May; 83(5):636-40. PubMed ID: 1378641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe and effective combination chemotherapy without cis-platinum for squamous cell carcinomas of the head and neck.
    Price LA; Hill BT
    Cancer Treat Rep; 1981; 65 Suppl 1():149-54. PubMed ID: 7198936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug chemotherapy (vincristine, bleomycin, and methotrexate [VBM]) with radiotherapy in stage III-IV squamous cell carcinoma of the head and neck.
    Rosso R; Merlano M; Sertoli MR; Campora E; Scarpati D; Borasi F; Pallestrini E
    Cancer Treat Rep; 1984; 68(7-8):1019-21. PubMed ID: 6204753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
    Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
    Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential combination chemotherapy of advanced head and neck carcinoma: re-evaluation of a highly effective regimen.
    Veronesi A; Barzan L; Magri MD; Tirelli U; Galligioni E; Trovò MG; Tumolo S; Comoretto R; Grigoletto E
    Strahlentherapie; 1981 Apr; 157(4):277-9. PubMed ID: 6166105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Lester EP; Kinnealey A; Matz GJ
    Laryngoscope; 1979 Dec; 89(12):1921-9. PubMed ID: 92740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy and chemotherapy in treatment of head and neck cancer.
    Dalley VM
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):173-9. PubMed ID: 75876
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.
    Dietz A; Vanselow B; Rudat V; Conradt C; Weidauer H; Kallinowski F; Dollner R
    Head Neck; 2003 Jan; 25(1):50-8. PubMed ID: 12478544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.